Lipid nanocarriers for topical application in psoriasis and psoriatic arthritis

Etudiant :SALA Mourad

Ecole doctorale :Array

Directeur ou Directrice :Nanovecteurs lipidiques pour une application topique dans le psoriasis et sa complication arthritique

Date de la soutenance :20170128

Commentaire :

Psoriasis is an auto-immune and chronic skin disease. Psoriatic arthritis is the main complication which is very disabling for patients. This pathology still remains incurable to date. The currently psoriasis indicated medicines use is limited by their side effects which are dose and use duration dependent. The aim of this work was to develop lipid based nanocarriers for skin targeting, especially the viable epidermis which is the main site of psoriasis physiopathology but also the dermis and beyond in order to reach the damaged articulations. Thanks to a new technique we developed and optimized called the double solvent displacement, based on a two-step phospholipid organization, we prepared diclofenac and cyclosporine A loaded lipid vesicles. Then, we evaluated their potential to cross the skin and target the skin layers of interest. After a systematic study to optimize preparation parameters, diclofenac and cyclosporine A loaded lipid vesicles displayed an encapsulation efficiency (EE %) between 50% and 90% respectively, according to the phospholipid concentration. After in vitro skin studies, we observed that the formulation containing the lower phospholipid concentration (8.5 mg/mL) allowed to encapsulate more than 80% of diclofenac and also to target the dermis and beyond. The formulation of cyclosporine A loaded lipid vesicles which encapsulates the higher amount (around 80%) is also the one containing the lower phospholipid concentration. Unlike to diclofenac, this formulation was not the better to target the viable epidermis whereas the formulation with the higher phospholipid concentration (15 mg/mL) was even though the EE% was of around 55%. The double solvent displacement is a very promising technique of lipid vesicle preparation, capable to produce monodisperse population of nanoscale carriers. This method is hardly impacted during scale-up and would be easy to implement at an industrial scale. This method was designed from the beginning to use skin penetration enhancer solvents but the scope of its applications still remains to be explored